News and analysis on the research-peptide industry — FDA regulation, compounding policy, supplier developments, and the forces shaping the market. Straight reporting for researchers who want to understand the landscape.
// Market Update · Regulatory History · FDA Framework · Titanborn Research // Editorial Note This article covers documented regulatory history based on published FDA guidance, Federal Register notices, and independent journalism. All facts are sourced and verifiable. This is educational content — not legal or political advice. In September 2023, the FDA restricted compounding…
// Market Update · Vendor Alternatives · Research Continuity · May 2026 // Editorial Note Peptide Sciences did not provide an official explanation for their closure. The analysis in this article is based on publicly available industry reporting, documented regulatory events, and independent third-party testing data. All facts cited are drawn from published sources. One…
No products in the cart.